Particia A Thompson

Title: The Innovative Contributions of Particia A Thompson

Introduction

Particia A Thompson is a notable inventor based in Tucson, AZ (US). She has made significant strides in the field of cancer research, particularly in the diagnosis and treatment of colorectal cancer. Her work has the potential to improve patient outcomes and guide treatment options based on genetic factors.

Latest Patents

Thompson holds a patent for her invention titled "Carcinoma diagnosis and treatment, based on ODC1 genotype." This invention provides methods and kits for predicting colorectal cancer patient survival, as well as the survival of patients with other invasive cancers linked to high levels of ODC activity. The patent also outlines how to select appropriate treatment options based on the allelic nucleotide sequence or SNP at position +316 of the ODC1 promoter gene. This innovative approach aims to guide treatment selection through the determination of the ODC1 promoter +316 position genotype.

Career Highlights

Throughout her career, Particia A Thompson has worked with prestigious institutions such as the University of Arizona and the University of California. Her research has focused on the intersection of genetics and cancer treatment, contributing valuable insights to the medical community.

Collaborations

Thompson has collaborated with esteemed colleagues, including Eugene W Gerner and Jason A Zell. These partnerships have furthered her research and expanded the impact of her work in the field of oncology.

Conclusion

Particia A Thompson's contributions to cancer diagnosis and treatment exemplify the importance of innovation in healthcare. Her patented methods and collaborative efforts continue to pave the way for advancements in cancer research and patient care.